Similar articles

• Cure- or care-oriented regimen for stage III non-small-cell lung cancer?

  Hotta K, Nagio T, Matsuo K, Kiura K. Hotta K, et al. J Clin Oncol. 2011 Apr 10;29(11):e320. doi: 10.1200/JCO.2010.32.6025. Epub 2011 Mar 14. J Clin Oncol. 2011. PMID: 21402605 No abstract available.
• [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].

  Mornex F. Mornex F. Rev Pneumol Clin. 2001 Nov;57(5 Pt 2):S29-32. Rev Pneumol Clin. 2001. PMID: 11924239 Review. French. No abstract available.
• [Progress in diagnosis and treatment of lung cancer].

  Fukuoka M. Fukuoka M. Nihon Naika Gakkai Zasshi. 2002 Mar 20;91 Suppl:15-22. Nihon Naika Gakkai Zasshi. 2002. PMID: 11989256 Review. Japanese. No abstract available.
• [Combined-modality therapy for lung cancer].

  Miura S, Yamamoto N. Miura S, et al. Nihon Rinsho. 2010 Jun;68(6):1121-8. Nihon Rinsho. 2010. PMID: 20535966 Review. Japanese.
• A case of stage IIIB lung cancer treated with concurrent chemoradiotherapy followed by successful tumor resection.

  Ujiie H, Akiyama H. Ujiie H, et al. Jpn J Clin Oncol. 2011 Nov;41(11):1312. doi: 10.1093/jjco/hyr155. Jpn J Clin Oncol. 2011. PMID: 22028282 No abstract available.